Best Anna Rehbein Podcasts (2024)

1
Myelitis Associated With Rheumatologic Disease - Part 2 3:20

10h ago3:20

3:20

In part two of this two-part series, Dr. Stacey Clardy and Dr. Elias Sotirchos discuss abandoning the term lupus myelitis and emphasize the importance of accurately naming and identifying each autoimmune condition. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200329By American Academy of Neurology

1
Myelitis Associated With Rheumatologic Disease - Part 1 4:38

1d ago4:38

4:38

In part one of this two-part series, Dr. Stacey Clardy and Dr. Elias Sotirchos discuss key features of inflammatory myelopathy in rheumatologic disease, helping to better characterize the underlying causes of lupus myelitis. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200329By American Academy of Neurology

1
Could GLP-1 Receptor Agonists Reduce the Risk of Neurologic Disorders? 1:30

1h ago1:30

1:30

Dr. Tesha Monteith discusses the Brain & Life article, “Could GLP-1 Receptor Agonists Reduce the Risk of Neurologic Disorders?” by Hallie Levine, available in the latest issue of Brain & Life or at brainandlife.org. Show reference: https://www.brainandlife.org/articles/new-weight-loss-drugs-may-help-neurologic-disorders…

1
CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 3 2:11

11h ago2:11

2:11

In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Ahmad Nehme discuss how to differentiate between CAA-RI and PACNS. Show reference: https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548By American Academy of Neurology

1
The Placebo Effect 1:02

1h ago1:02

1:02

Dr. Gregg Day and Dr. Kathryn T. Hall discuss the complexities of the placebo effect, its variability among patients, and the genetic factors that influence responses to placebo treatments.By American Academy of Neurology

1
CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 2 2:23

7h ago2:23

2:23

In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Ahmad Nehme discuss the underlying pathophysiology and how to diagnose primary angiitis of the CNS in clinical practice. Show reference: https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548By American Academy of Neurology

1
CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 1 2:11

3d ago2:11

2:11

In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Ahmad Nehme discuss how cerebral amyloid angiopathy and CAA-RI present in clinical practice and how to make a diagnosis. Show reference: https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548By American Academy of Neurology

1
Lab Minute - Vitamin D 4:28

2d ago4:28

4:28

Dr. Stacey Clardy discusses vitamin D in this lab minute.By American Academy of Neurology

1
Could Reducing Environmental Toxins Help Mitigate the Risk for Parkinson’s Disease? Where the Evidence Is Leading 4:28

3d ago4:28

4:28

Dr. Halley Alexander discusses the Neurology Today article, "Could Reducing Environmental Toxins Help Mitigate the Risk for Parkinson’s Disease? Where the Evidence Is Leading" by Gina Shaw, available in the November 7th issue of Neurology Today or at neurologytoday.com. Show reference: https://journals.lww.com/neurotodayonline/pages/articleviewer.a…

1
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 3 1:58

6d ago1:58

1:58

In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Jennifer L. Orthmann Murphy highlight important indicators for when to suspect hereditary spastic paraplegia, as well as guidelines for testing and interpreting results. Show references: https://www.neurology.org/doi/10.1212/NXG.0000000000200192 https://cshperspectives.cshl…

1
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 2 2:17

7d ago2:17

2:17

In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Jennifer L. Orthmann Murphy discuss practical approaches to genetic adrenoleukodystrophy. Show references: https://www.neurology.org/doi/10.1212/NXG.0000000000200192By American Academy of Neurology

1
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 1 2:06

8d ago2:06

2:06

In the first part of this three-part series, Dr. Justin Abbatemarco and Dr. Jennifer L. Orthmann Murphy discuss red flag symptoms that suggest the need for genetic testing in patients with white matter disease. Show references: https://www.neurology.org/doi/10.1212/NXG.0000000000200192 https://cshperspectives.cshlp.org/content/early/2024/08/10/cshp…

1
Early Treatment Cuts Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 2:56

9d ago2:56

2:56

Dr. Rae Bacharach discusses the Neurology Today article, “Early Treatment Cuts Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease,” by Gina Shaw, available in the latest issue of Neurology Today or at neurologytoday.com. Show reference: https://journals.lww.com/neurotodayonline/pages/default.aspx https://jamanetwork.com…

1
Interventions for the Acute Management of Migraine Episodes in Adults - Part 3 4:47

15d ago4:47

4:47

In the final part of this three-part series, Drs. Tesha Monteith, Messoud Ashina, and Andrea Cipriani discuss what you need to know about analyzing network meta-analysis. Show reference: https://www.bmj.com/content/386/bmj-2024-080107By American Academy of Neurology

1
Eculizumab Use in Neuromyelitis Optica Spectrum Disorders 1:55

14d ago1:55

1:55

Drs. Justin Abbatemarco, Marius Ringelstein, and Ilya Ayzenberg discuss a new class of complement inhibitors that we're using in NMOSD. Show reference: https://www.neurology.org/doi/full/10.1212/WNL.0000000000209888By American Academy of Neurology

1
Interventions for the Acute Management of Migraine Episodes in Adults - Part 2 4:33

15d ago4:33

4:33

In part two of this three-part series, Drs. Tesha Monteith, Messoud Ashina, and Andrea Cipriani discuss clinical pearls on how to select an acute treatment plan for migraine. Show reference: https://www.bmj.com/content/386/bmj-2024-080107By American Academy of Neurology

1
Interventions for the Acute Management of Migraine Episodes in Adults - Part 1 4:49

20d ago4:49

4:49

In the first part of this three-part series, Drs. Tesha Monteith, Messoud Ashina, and Andrea Cipriani explain the significance of this study and how its findings can be applied in clinical practice. Show reference: https://www.bmj.com/content/386/bmj-2024-080107By American Academy of Neurology

1
Timing of Anticoagulation Resumption and Risk of Ischemic and Hemorrhagic Complications in Patients With ICH and Mechanical Heart Valves 2:26

17d ago2:26

2:26

Dr. Jodie Roberts and Dr. Amra Sakusic discusses the relationship between reversal therapy and ischemic stroke, between duration off anticoagulation and risk of ischemic strokes or systemic embolism. Learn more about the Neurology Practice Current section and fill out the survey now. Show reference: https://survey.alchemer.com/s3/7969148/Practice-C…

1
Women History Minute - The Women of the Cajal School 4:00

20d ago4:00

4:00

In this Women's History Minute, Dr. Alison Christy discusses the Cajal School of Neuropathology in Spain and emphasizes the importance of mentorship.By American Academy of Neurology

1
Revised Criteria for Diagnosis and Staging of Alzheimer Disease 2:10

27d ago2:10

2:10

Dr. Greg Cooper and Dr. Clifford R. Jack Jr. discuss objective criteria for diagnosis and staging Alzheimer disease, highlighting recent advancements in biomarkers to bridge the gap between research and clinical practice. Show reference: https://pubmed.ncbi.nlm.nih.gov/38934362/By American Academy of Neurology

1
End-of-Life Health Care Service Use and Cost 2:02

22d ago2:02

2:02

Dr. Gordon Smith and Dr. Whitley Aamodt discuss end-of-life care for patients with neurodegenerative diseases, focusing on healthcare utilization, hospice enrollment, and the importance of early conversations about care preferences. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209925…

1
Women History Minute - Cecile Vogt 4:16

27d ago4:16

4:16

Dr. Alison Christy delves into another women's history minute to discuss Cecile Vogt.By American Academy of Neurology

1
Neurology on the Hill 1:35

28d ago1:35

1:35

Dr. Jason Crowell talks about Neurology on the Hill and how you can get involved if you are interested. Show reference: https://www.aan.com/policy-and-guidelines/capitol-hill-report/By American Academy of Neurology

1
A Comparison of Side Effects for Four First-line Antiseizure Medications 3:27

1M ago3:27

3:27

Dr. Halley Alexander discusses the Neurology Today article, "A Comparison of Side Effects for Four First-line Antiseizure Medications" by Stacey Burling, available in the September 19th issue of Neurology Today or at neurologytoday.com. Show reference: https://journals.lww.com/neurotodayonline/fulltext/2024/09190/a_comparison_of_side_effects_for_fo…

1
Epilepsy in Patients With Primary CNS Lymphoma 1:09

28d ago1:09

1:09

Dr. Kait Nevel and Dr. Oumaima Aboubakr discuss the prevalence of epilepsy in primary CNS lymphoma. Show reference: https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209748By American Academy of Neurology

Podcasts Worth a Listen

Anna Rehbein Podcasts

Podcasts Worth a Listen

1
Neurology Minute

American Academy of Neurology

1
Myelitis Associated With Rheumatologic Disease - Part 2 3:20

1
Myelitis Associated With Rheumatologic Disease - Part 1 4:38

1
Could GLP-1 Receptor Agonists Reduce the Risk of Neurologic Disorders? 1:30

1
CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 3 2:11

1
The Placebo Effect 1:02

1
CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 2 2:23

1
CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 1 2:11

1
Lab Minute - Vitamin D 4:28

1
Could Reducing Environmental Toxins Help Mitigate the Risk for Parkinson’s Disease? Where the Evidence Is Leading 4:28

1
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 3 1:58

1
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 2 2:17

1
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 1 2:06

1
Early Treatment Cuts Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 2:56

1
Interventions for the Acute Management of Migraine Episodes in Adults - Part 3 4:47

1
Eculizumab Use in Neuromyelitis Optica Spectrum Disorders 1:55

1
Interventions for the Acute Management of Migraine Episodes in Adults - Part 2 4:33

1
Interventions for the Acute Management of Migraine Episodes in Adults - Part 1 4:49

1
Timing of Anticoagulation Resumption and Risk of Ischemic and Hemorrhagic Complications in Patients With ICH and Mechanical Heart Valves 2:26

1
Women History Minute - The Women of the Cajal School 4:00

1
Revised Criteria for Diagnosis and Staging of Alzheimer Disease 2:10

1
End-of-Life Health Care Service Use and Cost 2:02

1
Women History Minute - Cecile Vogt 4:16

1
Neurology on the Hill 1:35

1
A Comparison of Side Effects for Four First-line Antiseizure Medications 3:27

1
Epilepsy in Patients With Primary CNS Lymphoma 1:09

Quick Reference Guide

zproxy.org